Andrew Shorr, MD, MPH, MBA

Section Director, Pulmonary and Critical Care Medicine
Medstar Washington Hospital Center

Disclosure(s): Basilea: Advisor/Consultant, Grant/Research Support

Poster(s):

• (P-109) A Phase I First-in-Human Study to Evaluate the Safety and Pharmacokinetic (PK) Properties of the Intravenously (IV) Administered OMN6, A Novel Antimicrobial Peptide Targeting Acinetobacter baumannii (AB), in Adults including Older Healthy Volunteers (HVs) Subjects
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-827) Epidemiology of Favorable vs. Unfavorable Outcomes in Hospitalized Patients with S. aureus Bacteremia in the US: A Multicenter Retrospective Cohort Study
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT